Analysts cited data from a phase one study showing the highest dose of Amgen’s MariTide was linked to roughly 4% loss of bone ...

Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a day after ...

In this photo illustration, Amgen logo is displayed on a smartphone with a S&P ... [+] index website background. (Photo ...

Amgen addresses safety concerns for its weight loss drug MariTide after new data suggests a potential 4% reduction in bone ...

CEO Bob Bradway said Amgen is "well advanced" in preparing to launch a Phase 3 testing round of MariTide in order to have ...

Popular weight-loss drugs are helping some runners lose weight and crush PRs. Experts have some real concerns.

Recent health news highlights include Amgen addressing bone density concerns, AstraZeneca revising its financial outlook ...

Jefferies reviewed public data from the Phase 1 trial of AMG-133 showing additional measurements of bone density from obesity patients, which ...

Dear Susan, While osteoporosis is much more common in adults age 60 and older, it can strike younger people too. In fact, ...

She’s maintaining her weight loss on a less-frequent dose of the GLP ... about malnourishment and the loss of muscle mass, ...